Procainamide Hydrochloride Injection
Product Images NDC 14789-901

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Procainamide Hydrochloride (NDC 14789-901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pro0k 0011 01

Chemical structure of Procainamide Hydrochloride, depicting its molecular arrangement including the amide group, aromatic ring, and hydrochloride component. The molecular weight shown is approximately 271.7 grams per mole.*

FDA Label Image

Pro0k 0011 02

Packaging label for Procainamide Hydrochloride Injection, USP, 1,000 mg per 2 mL (500 mg/mL), by Nexus Pharmaceuticals LLC. The label states it is for injection via intramuscular or intravenous routes, supplied as 10 vials of 2 mL multiple-dose vials. It includes warnings about metabissulfite content and storage instructions at 20-25°C. The label also lists active ingredients and notes the container closure does not contain natural rubber latex.*

FDA Label Image

Pro0k 0011 03

Procainamide Hydrochloride Injection USP 1,000 mg/2 mL (500 mg/mL) label for a 2 mL multiple-dose vial. The label lists the active ingredient as procainamide HCl USP 500 mg/mL, includes methylparaben 1 mg/mL as a preservative, and specifies storage instructions at 20° to 25°C. It is manufactured by Nexus Pharmaceuticals LLC in Germany and includes warnings about metabisulfites content.*

FDA Label Image

Pro0k 0011 04

Packaging label for Procainamide Hydrochloride Injection USP, 100 mg/mL (1,000 mg/10 mL), manufactured by Nexus Pharmaceuticals LLC. This label is for a box containing 10 multiple-dose vials of 10 mL each. The label includes storage instructions, warnings about containin metabolisulphite, aseptic technique guidance, and manufacturing information indicating production in Germany for Nexus Pharmaceuticals, Inc., Lincolnshire, IL.*

FDA Label Image

Pro0k 0011 05

Procainamide HCL Injection, USP 100 mg/mL (1,000 mg/10 mL) in a 10 mL multiple-dose vial. The label includes active ingredient content, preservatives, storage temperature, and manufacture information for Nexus Pharmaceuticals LLC. The product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.